文献速递关节外科创伤骨科

反向肩关节置换术治疗脱位性关节病的临床结局:配对病例对照研究

Clinical outcomes in patients undergoing reverse shoulder arthroplasty for dislocation arthropathy : a matched case-control study.
PubMed 文献 · Bone Joint J · 2025-09-01

这项回顾性配对队列研究纳入22例脱位性关节病患者与44例原发性骨关节炎伴盂骨缺损患者,均接受同一术者反向全肩关节置换术。两组假体生存率分别为100%与98%,所有患者报告结局与活动度均显著改善且组间无显著差异,并发症率分别为9%与11%。结论认为脱位性关节病患者行反向全肩关节置换术的临床结果与骨关节炎患者相当,但需要更长期随访。

要点

  • 脱位性关节病组假体生存率100%,骨关节炎组98%。
  • 两组所有患者报告结局与活动度均显著改善,改善幅度组间无显著差异。
  • 并发症率脱位性关节病组9%,骨关节炎组11%。

核心结论

  • 脱位性关节病患者行反向全肩关节置换术的临床结果与配对骨关节炎患者相当。
  • 这些发现提示反向全肩关节置换术是脱位性关节病的成功手术治疗,但需要更长期随访。

研究设计与样本

  • 回顾性配对队列研究,纳入2011年至2021年间由同一术者治疗的22例脱位性关节病患者,以及44例接受反向全肩关节置换术的配对骨关节炎患者。
  • 所有患者随访至少两年,使用两种反向全肩关节置换系统之一,两者均具有外侧化盂球、135°颈干角和非骨水泥肱骨组件,区别在于嵌合式与覆合式肱骨托盘。
  • 盂骨以偏心方式磨锉直至基板覆盖至少90%,未使用植骨或增强型盂组件。
  • 术前和末次随访记录活动度与患者报告结局。

主要发现

  • 末次随访假体生存率脱位性关节病组为100%,骨关节炎组为98%。
  • 两组所有患者报告结局和所有活动度均显著改善,且这些改善组间无显著差异。
  • 并发症率两组相似,脱位性关节病组为9%,骨关节炎组为11%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文指出需要更长期随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Dislocation arthropathy of the shoulder is an advanced arthritis resulting from recurrent glenohumeral dislocation with or without previous stabilization surgery. The aim of this study was to compare the clinical results of reverse total shoulder arthroplasty (RTSA) in patients with dislocation arthropathy with those with primary osteoarthritis (OA) and glenoid bone loss. METHODS: This was a retrospective matched cohort study including 22 patients with dislocation arthropathy who were treated by one surgeon between 2011 and 2021 and a matched group of 44 patients who were also treated with RTSA, for OA. All patients had a minimum follow-up of two years and were treated with one of two RTSA systems, both with a lateralized glenoid sphere, a 135° neck-shaft angle and an uncemented humeral component, but differing by inlay versus onlay humeral tray. The glenoids were reamed eccentrically until there was at least 90% cover of the baseplate. No bone grafting or augmented glenoid components were used. Range of motion (ROM) and patient-reported outcome measures (PROMs) were recorded preoperatively and at final follow-up. RESULTS: Implant survival at final follow-up was 100% in the dislocation arthropathy group and 98% in the OA group. Both groups showed significant improvements in all PROMs and all ROMs, and there was no significant difference in these improvements between the groups. The complication rate was similar in the two groups (9% in the dislocation arthropathy group and 11% in the OA group). CONCLUSION: The clinical results of RTSA performed in patients with dislocation arthropathy were comparable to those in a matched group of patients with OA. Although these findings suggest that RTSA is a successful surgical treatment for patients with dislocation arthropathy, longer follow-up is needed.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Goldfarb SI, Okeke L, Łukasiewicz P, et al. Clinical outcomes in patients undergoing reverse shoulder arthroplasty for dislocation arthropathy : a matched case-control study. Bone Joint J. 2025. PMID: 40887061. doi:10.1302/0301-620X.107B9.BJJ-2024-1328.R2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。